首页> 外国专利> Chimeric Cytokine Receptor Capable of Converting Immunosuppressive Signal to Immunostimmulatory Signal Immune Cell Expressing the Same and Anti-Cancer Use Thereof

Chimeric Cytokine Receptor Capable of Converting Immunosuppressive Signal to Immunostimmulatory Signal Immune Cell Expressing the Same and Anti-Cancer Use Thereof

机译:能够将免疫抑制信号转换为表达其相同和抗癌的免疫抑制信号免疫细胞的嵌合细胞因子受体

摘要

The present invention relates to a chimeric cytokine receptor capable of converting an immunosuppressive signal into an immune activation signal, an immune cell expressing the same, and a pharmaceutical composition for the treatment of cancer comprising the immune cell as an active ingredient. Immune cells expressing the chimeric cytokine receptor of the present invention can exert a stronger cytotoxic effect on cancer by converting an immunosuppressive signal into an immune activation signal in a microtumor environment in which immunosuppressive cytokines exist. Immune cells expressing the chimeric cytokine receptor of the present invention can be used as a cell therapy for cancer treatment.
机译:本发明涉及一种能够将免疫抑制信号转化为免疫活化信号的嵌合细胞因子受体,表达相同的免疫细胞,以及用于治疗包含免疫细胞作为活性成分的癌症的药物组合物。表达本发明的嵌合细胞因子受体的免疫细胞可以通过将免疫抑制信号转化为癌症中的免疫激活信号来对癌症发起更强的细胞毒性作用,其中存在免疫抑制细胞因子。表达本发明的嵌合细胞因子受体的免疫细胞可用作癌症治疗的细胞疗法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号